The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

Management of excessive daytime sleepiness (EDS) includes both pharmacologic and nonpharmacologic options, depending on its underlying cause.

If you currently have eye drops in your medicine cabinet, make sure they're not part of a recent recall. Plus, how to buy ...

A doctor has issued a warning that a commonly taken medication could lead to an "intolerable" two-month symptom.

Organic phosphorescence materials offer advantages for bioimaging applications, but most of them are excited exclusively by ultraviolet light, which poses risks to living organisms. Here, the ...

Almeida highlighted the increasing prevalence of diabetic macular edema and the importance of developing safe, well-tolerated treatments.

Subtle pupil dilation and changes in expression have been found to be a new way for medical professionals to detect tinnitus.

National Pharmacy Association chiefs have now warned chemists have seen a dramatic uptick in patients seeking advice on how ...

Glaucoma management is shifting toward earlier, drop-sparing interventions using sustained drug delivery and advanced laser ...

A vitamin supplement that improves metabolism in the eye appears to slow down damage to the optic nerve in glaucoma. The researchers behind the study have now started a clinical trial on patients.

Reproxalap ophthalmic solution 0.25% reached the primary endpoint in a second phase 3 dry eye chamber trial, according to Aldeyra Therapeutics.